Table 1 Demographics of patients and controls
From: Mean platelet volume: a controversial marker of disease activity in Crohn’s disease
Crohn’s disease (n= 61) | Control group (n= 50) | P value | |
|---|---|---|---|
Age (years) | 32.4 ± 1.59 | 34.0 ±1.44 | 0.133 |
Male (%) | 40 (65.6%) | 35 (70.0%) | 0.686 |
Smoking | 15 (24.6%) | 11 (22.0%) | 0.709 |
Body mass index (kg/m2) | 18.4 ± 0.526 | 19.3 ± 0.507 | 0.427 |
Active disease | 29 (47.5%) | – | – |
Age (%) | |||
A1 (≤16 years) | 9 (14.7%) | – | – |
A2 (17–40 years) | 37 (60.7%) | – | – |
A3 (>40 years) | 15 (24.6%) | – | – |
Disease location (%) | |||
L1 (ileal) | 33 (54.1%) | – | – |
L2 (colonic) | 10 (16.4%) | – | – |
L3 (ileocolonic) | 18 (29.5%) | – | – |
+ L4 (upper gastrointestinal tract) | 3 (4.92%) | – | – |
Disease behavior (%) | |||
B1 (inflammatory) | 9 (14.7%) | – | – |
B2 (stricturing) | 32 (52.5%) | – | – |
B3 (penetrating) | 20 (32.8%) | – | – |
+ P (perianal) | 3 (4.92%) | – | – |